Yared Hailemichael
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, CAR-T cell therapy research, T-cell and B-cell Immunology
Most-Cited Works
- → Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion(2013)446 cited
- → Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity(2022)325 cited
- → Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice(2014)230 cited
- → Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy(2020)166 cited
- → Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release(2012)160 cited
- → The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies(2020)156 cited
- → Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy(2010)120 cited
- → IFN-α Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity(2009)111 cited
- → Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain(2017)102 cited
- → Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression(2017)101 cited